erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
derek valenzuela had a tough time coming up with words of gratitude for st. jude staffers.
.
.
| featured:
.
.
. seems to be in a lot of legal trouble as of late. everyone from her exes to the kardashians donated
.
activity
.